14 research outputs found
Randomized, placebo-controlled, phase IV pilot study of ramosetron to evaluate the co-primary end points in male patients with irritable bowel syndrome with diarrhea
Get PDFEvaluation of the irritable bowel syndrome severity index in Japanese male patients with irritable bowel syndrome with diarrhea
Full text linkEvaluation of Efficacy Variables in Clinical Study of Irritable Bowel Syndrome with Diarrhea
No full textEvaluation of Efficacy Variables in Clinical Study of Irritable Bowel Syndrome with Diarrhea
No full textSu2062 Effects of Ramosetron on Male Patients With Irritable Bowel Syndrome With Diarrhea: Randomized, Placebo-Controlled Trial
No full textAnalysis of 109Ag MAS NMR chemical shieldings observed in Ag(x)Cu(1- x)I crystals
Get PDF109Ag NMR signals in AgxCu1−xI crystals were shifted to a low field relative to that in solid AgI with decreasing the unit cell constant analogously to 63Cu MAS NMR signals reported in a previous study. The observed chemical shieldings were analysed using the results of Ag and Cu NMR shielding calculations of tetrahedral (Td) MI43− (M = Ag, Cu) complex ions with the ab initio GAUSSIAN 94 program using a double-ζ basis set for the Ag, Cu, and I atoms. Since the shift is explained dominantly by the paramagnetic shielding term, which depends on the d-hole and p-electron densities in Ag or Cu atoms for the MI43− complex ions, the observed 109Ag shift moved to a low field with decreasing the lattice constant, corresponding to an increase in the d-hole and p-electron densities for AgI43− (RAg–I = 2.68, 2.73, 2.77 Å) relative to the AgI43− (RAg–I = 2.81Å) ion
Mo1281 Optimal Dose of Ramosetron in Female Patients With Irritable Bowel Syndrome With Diarrhea: A Randomized, Placebo-Controlled Phase II Trial
No full text315 Effect of Ramosetron in Female Patients With Irritable Bowel Syndrome With Diarrhea: A Randomized, Placebo-Controlled Phase III Trial
No full text
